ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SNG Synairgen Plc

4.675
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.675 4.36 4.99 - 60,335 08:00:27
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.53 9.41M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.68p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.41 million. Synairgen has a price to earnings ratio (PE ratio) of -0.53.

Synairgen Share Discussion Threads

Showing 1776 to 1799 of 99175 messages
Chat Pages: Latest  79  78  77  76  75  74  73  72  71  70  69  68  Older
DateSubjectAuthorDiscuss
31/3/2020
15:45
This could be a big help as well.

hxxps://theduran.com/france-sanctions-chloroquine-after-78-of-80-patients-completely-recover-from-covid-19-within-five-days/?fbclid=IwAR01efiBqfI9cgyIWtuePwOF0OT3XBRiJGY6c7x_-BK6GcUUofz-EucO4Uk

donald tramp
31/3/2020
15:44
And that's really my point Nobby. People will share any positive information they have or believe they have with someone, who passes it to someone else 'confidentially' and so on.

It's an extraordinary set of circumstances not seen before in our lifetime.

jev1
31/3/2020
15:42
Ah Nobby I was hoping for the reasoning from tburns, it would have made interesting reading....
d1nga
31/3/2020
15:40
Nobody will know the result before it is unblinded. It is not impossible that some of the medical participants might have a clue if it works spectacularly well because some patients will get better very quickly but absolutely no-one will know for sure! After all they have no idea who is getting placebo and who is getting drug......
nobbygnome
31/3/2020
15:39
Bulgarian

We're talking a completely different ball game to a share that can be influenced positively or negatively by posters.

A global pandemic, the last one was a century ago.
Markets and Commodities decimated, the worst in decades.
Society as we know it, closed down.

There is a desperate need for a solution and at present SNG001 is one of the very few that has the potential to make a real difference.

This is the driver here.

jev1
31/3/2020
15:27
I have yet to observe ANY share that 6 months after its time in the RAMPEROONIE Spotlight fell less than 50% once Degsey / Tidy2s consortium / boiler room finished with it.

They normally crater much quicker than that.

Don't think pump & dump?

;-)

bulgarian
31/3/2020
15:22
Can you explain how they would know?

Tia

d1nga
31/3/2020
15:19
One thing is for sure is that the Doctors and Epidemiologists at Southampton will know the results before the market and even SNG themselves do. Watch out for block buys around 10 days from now as peeps in the know potentially take advantage.
tburns
31/3/2020
15:13
Unfortunately I am not smart enough to trade in and out of a share.

However, Gilead's market cap increased by $11 billion on the news that they were testing their antiviral for this virus. And weeks later that increase has been maintained.

For Fuji and their treatment I believe it was an increase of £3 billion on announcement.

Synairgen's market cap is £70m ish. So I am happy to hold since IMHO the market cap does not reflect true value yet. It will in time. Although like others I will take some off the table before results. GLA

pdt
31/3/2020
15:08
If you can't write a post without name calling, you've already lost the argument but I guess that's just another feature your village must love about you. A bespoke form of tourettes even.

____

Triple-blind (i.e., triple-masking) studies are randomised experiments in which the treatment or intervention is unknown to (a) the research participant, (b) the individual(s) who administer the treatment or intervention, and (c) the individual(s) who assess the outcomes.

jev1
31/3/2020
15:00
Triple blind trial?!!! WTF?You clearly are a moron when it comes to scientific studies. Maybe you shouldn't be invested here.
spqstrader
31/3/2020
14:57
SPQS

I know you must be getting cabin fever by now, not having regular access to your village but rest assured, most people in your village will still have access to comedy for entertainment. Yours was just the icing on the cake.

It's not a triple blind trial, which means there will still be some individuals involved that will know who is receiving what.

The circumstances surrounding the need for this trial are extraordinary. People behave differently under such pressures.

In a similar way to you venting your insecure frustrations on this thread.

jev1
31/3/2020
14:46
No surprise there’s a bit of profit taking today after some pretty hefty rises of late. I’m quite happy to sit and wait as the more we get into the trial and the closer we get to the results, the share price is going to be way higher than it is at the moment.
lunus1
31/3/2020
14:32
After 7 years of trying to make a SARS vaccine they gave up.
tidy 2
31/3/2020
14:32
Might buy back with the proceeds of my morning sale this pm - watching
toffeeman
31/3/2020
14:30
There will be no vaccine that works 100% they are hit and miss as is the flu vaccine. Treatment and prevention is the only way.
tidy 2
31/3/2020
14:11
Agreed duxy
bountyhunter
31/3/2020
14:10
Fincap said 360
bobaxe1
31/3/2020
14:08
People forget, spring 2021 is 12 months away. This a good time to add now and hold a recovery stock for a nice finish in 2022. One that is heavily down due to this current crisis.Getting a drug to market within 12 months will be a phenomenal feat for any company. I believe JNJ are well positioned to do this and produce in the quantities, the world will need. And yes NYSS:JNJ, is a very save recovery stock than many of the bin liner stocks currently trading as oilys on AIM.
duxy786
31/3/2020
13:57
Good job SNG are in the focus of Biliionaire Billy Gates for the USA. :o)
jev1
31/3/2020
13:49
GSK and other big pharmas are quite capable of producing vaccines at scale, not just JNJ. JNJ don't have world domination of the vaccine market although they are a big player and as such it takes a lot to shift their mega market cap given their huge range of interests. I'm not saying the price won't go up a bit (but don't expect it to multibag) I thought about an investment in JNJ myself yesterday. Presumably you bough NYSE:JNJ duxy?
It's probably a safe investment in these troubled times compared to most others.

bountyhunter
31/3/2020
13:47
Sadly the same for anyone developing a vaccine except US companies where I think Trump will fast track those working with anti-malaria drugs.
duxy786
31/3/2020
13:47
Yes tickboo up to a year and apparently that's fasttrack but I've no doubt that some kind of preventative social measures will be needed until a widespread vaccine is available. Start of 2021 seems like the very earliest? We may be stuck watching the Green Goddess and eating whatever we can get for sometime yet.
bountyhunter
31/3/2020
13:46
If you believe that....carry on.
duxy786
Chat Pages: Latest  79  78  77  76  75  74  73  72  71  70  69  68  Older

Your Recent History

Delayed Upgrade Clock